Risk of premature cerebrovascular disease in patients with ankylosing spondylitis
Related Experiment Video
Updated: Mar 21, 2026

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice
Published on: October 27, 2023
Xingwen Zhang1, Ruozhuo Liu1, Jing Wang1
1Chinese PLA General Hospital, Beijing.
Insights
Ankylosing spondylitis patients experience cerebrovascular disease at a younger age, suggesting increased premature vascular risk. Small-vessel inflammation may contribute to this condition in AS patients.
Area of Science:
- Rheumatology
- Neurology
- Cardiovascular Medicine
Background:
- Ankylosing spondylitis (AS) is linked to higher coronary artery disease risk.
- Cerebrovascular disease risk in AS patients is not well-established.
Purpose of the Study:
- To investigate cerebrovascular risk profiles in AS patients with cerebrovascular disease.
- To compare these profiles with cerebrovascular disease patients without AS.
Main Methods:
- Retrospective analysis of 34 AS patients with ischemic cerebrovascular disease and 597 controls.
- Evaluation of age, gender, cerebrovascular risk factors, and laboratory results.
Main Results:
- AS patients were significantly younger (56.2 years) than controls (63.0 years) at cerebrovascular disease onset.
- No significant associations found between AS, risk factors, and inflammatory markers (ESR, CRP).
- AS patients showed a high frequency of small-vessel occlusion stroke.
Conclusions:
- AS patients face an increased risk of premature cerebrovascular disease.
- Premature atherosclerosis may be associated with AS.
- Small-vessel inflammation might play a role in AS-related vascular disease pathogenesis.
Objectives:
Patients with ankylosing spondylitis (AS) are at an elevated risk for the development of coronary artery disease, but the risk cerebrovascular disease among these patients remains incompletely understood. We investigated the cerebrovascular risk profiles of patients with a cerebrovascular disease and AS and compared these profiles to those of cerebrovascular disease patients without AS.
Methods:
We retrospectively analyzed 34 patients with ischemic cerebrovascular disease also diagnosed with AS and 597 controls without AS with respect to patient age, gender, cerebrovascular risk factors, and laboratory test results.
Results:
AS patients were significantly younger than control patients in this study (56.2±13.5 years vs. 63.0±13.4 years, respectively; p=0.004). Logistic regression analysis did not indicate significant relationships between gender, cerebrovascular risk factors, and biochemical risk factors in AS patients, nor were any significant relationships found between erythrocyte sedimentation rate or C-reactive protein and biochemical risk factors. A low frequency of large-artery atherosclerosis and high frequency of small-vessel occlusion according to TOAST classification were found in AS patients with stroke.
Conclusions:
Among the patients included in this study, patients with AS sought treatment for cerebrovascular disease were at a younger age compared to control patients without AS. Thus, our results indicate that AS patients have an increased risk for the premature onset of cerebrovascular disease. And the premature atherosclerosis may associate with the patients with AS. Furthermore, the high frequency of the small-vessel stroke subtype in AS patients indicates that small-vessel inflammation may be involved in the pathogenesis of vascular diseases in AS patients. Further prospective study with more samples will be needed to confirm this point of view.
More Related Videos
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Peripheral Artery Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Rheumatic Heart Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...

